PP
SRNE

PFS Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

PFS Partners’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,063
Closed -$942 – 400
2022
Q4 		$942 Buy
+1,063
New +$942 ﹤0.01% 347